INS and metabolic dysfunction-associated steatotic liver disease: The liver is one of the major organs of insulin action, thus insulin resistance plays a pivotal role in the progression of NAFLD, which results in an increase in hepatic lipogenesis and subsequent accumulation of fatty acids in the liver (Ota et al., 2007; Bugianesi et al., 2010; Kitade et al., 2017).